Yadanzigan
CAS No. 76588-87-9
Yadanzigan ( Yadanzigan )
产品货号. M39223 CAS No. 76588-87-9
Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥3116 | 有现货 |
|
| 10MG | ¥4456 | 有现货 |
|
| 25MG | ¥6687 | 有现货 |
|
| 50MG | ¥9040 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Yadanzigan
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice.
-
产品描述Yadanzigan (YDZG) is an anti-inflammatory agent and a NLRP3 inhibitor. Yadanzigan specifically inhibits NLRP3 activation via inhibiting NF-κB pathway and Reactive Oxygen Species production. Yadanzigan also moderates LPS -induced acute lung injury (ALI) in mice.
-
体外实验Yadanzigan (5 mg/kg, 10 mg/kg; 静脉注射; 共 3 次) 预防 LPS 诱导的小鼠急性肺损伤。Animal Model:Male BABL/C mice (18-22 g) Dosage:5 mg/kg, 10 mg/kg Administration:Intravenous injection; dose at 2 h prior to and 6 h, 12 h after LPS induction Result:Reduced LPS-induced infiltration of inflammatory cells and cytokine levels, such as TNF-α and IL-6. Inhibited NLRP3 inflammasome activation in lung tissue.Resulted significantly greater survival rate.
-
体内实验Yadanzigan (20, 40, 80 μM; 1 h) 促进 RAW264.7 巨噬细胞的 Nrf2 从细胞质转位到细胞核。Yadanzigan (20 μM; 1 h) 抑制 LPS 诱导 HEK293T 细胞线粒体活性氧 (ROS) 的生成 (1 μg/mL; 6 h)。Yadanzigan (40 μM; 1 h) 显著阻断 J774A 细胞在LPS和ATP诱导下 NLRP3 炎性小体的形成。Yadanzigan (2.5-10 μM 或 10-40 μM; 1, 6, 12 h) 增强J774A.1 和 THP-1 细胞中 TRIM31 表达,促进 NLRP3 蛋白降解。Western Blot AnalysisCell Line:J774A.1, and THP-1 cells Concentration:For J774A.1: 2.5 μM, 5 μM, and 10 μM; For THP-1: 10 μM, 20 μM, and 40 μM Incubation Time:For J774A.1: 6 h, 12 h; For THP-1: 1 hour; 2 h before 1 μg/mL LPS stimulated and another 30 min before 5 mM ATP induced Result:Led to a sharp decrease in NLRP3 expression in J774A.1 cells.Led to a large decrease in NLRP3 protein expression in a dose-dependent manner in THP-1 cells.Immunofluorescence Cell Line:RAW264.7 macrophages, THP-1 cells Concentration:20, 40, and 80 μM Incubation Time:Pre-treated for 1 h, continue to incubate for 18 h Result:Decreased caspase-1 p20 activation and mature IL-1β and inhibited cleaved caspase-1 release into supernatants.
-
同义词Yadanzigan
-
通路Others
-
靶点Other Targets
-
受体NLRP3 inflammasome
-
研究领域———
-
适应症———
化学信息
-
CAS Number76588-87-9
-
分子量574.6
-
分子式C26H38O14
-
纯度>98% (HPLC)
-
溶解度———
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Human IgE Pentapepti...
Pentigetide 是一种合成肽 (Asp-Ser-Asp-Pro-Arg 或 D-S-D-P-R),也被称为“人 IgE 五肽”的“HEPP”。由于 HEPP 中的天冬氨酸转化为天冬酰胺,Pentigetide 在几种不同体系中均不能产生 IgE 抑制作用。
-
Chitinase, Serratia ...
Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).
-
[D-Ala2, DArg6] Dyno...
[D-Ala2, DArg6] Dynorphin A, (1-13), porcine
021-51111890
购物车()
sales@molnova.cn

